Chinese medicine: Shanghai Xinxing completely stopped production verification – financial sector



[ad_1]

Chinese medicine: Shanghai Xinxing completely stopped production verification

On the evening of February 10, China Pharmaceuticals (600056) explained the suspension of Shanghai Xinxing's lot number from its controlling subsidiary. In relation to the impact on listed companies, Securities Times ยท reporter and noted that at present, Chinese medicine holds …

See full article in Google Newsin

[ad_2]

Source link